Andrew Blumenfeld, MD
Dr. Blumenfeld focuses on addressing the multi-faceted needs of headache sufferers. These needs include acute care, educational programs and other specialty services. This comprehensive approach treats the whole person in a highly individualized manner and addresses the growing demand for one-stop treatment services.
Dr. Blumenfeld has published widely and has been an active researcher in headaches and multiple sclerosis.
Dr. Blumenfeld was also a principal investigator of the largest research study showing that Botulinum toxin type A, known as Botox, is an effective preventive therapy for headache pain in chronic sufferers. He has since accrued strong experience in Botox therapy, yet continues to be active in studies that evaluate a wide range of therapies.
He believes in an individualized, patient-centered approach that empowers patients to take control of their own health care. This requires that they are fully informed about alternative therapies, and that physicians and patients make joint decisions about treatment, based on lifestyles and other medical factors. In this capacity, he regularly addresses national pharmaceutical meetings, medical conferences, continuing education seminars, and community events.
An avid bicyclist, he participated in the Race Across America in 2003 and 2004. He also enjoys running and spending time with his family.
- United Council for Neurologic Subspecialties, Headache Medicine, 2008
- American Board of Psychiatry and Neurology, Neurology, 1991
- University of Witwatersrand, MD, 1981
- Johannesburg General Hospital, MD, 1982
- University of Massachusetts Medical School, Neurology, 1989
- Johannesburg General Hospital, Neurology, 1986
- 1 Military Hospital, Internal Medicine, 1984
- University of Massachusetts Medical Center, Neurophysiology, 1990
If you see an error or omission on a provider’s profile page, please contact us.